Thioredoxin reductase-1 mediates curcumin-induced radiosensitization of squamous carcinoma cells

Cancer Research

Volumn 70, Issue 5, 2010, Pages 1941-1950

  Javvadi, Prashanthi ^a   Hertan, Lauren ^a   Kosoff, Rachelle ^a   Datta, Tatini ^a   Kolev, Johann ^a   Mick, Rosemarie ^a   Tuttle, Stephen W ^a   Koumenis, Constantinos ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CURCUMIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; REACTIVE OXYGEN METABOLITE; THIOREDOXIN REDUCTASE 1;

ARTICLE; CANCER CELL; CATALYSIS; CELL SURVIVAL; CLONOGENESIS; CONTROLLED STUDY; DRUG SENSITIVITY; ENZYME ACTIVATION; ENZYME INHIBITION; FADU CELL; GENE DELETION; GENE OVEREXPRESSION; HELA CELL; HUMAN; HUMAN CELL; IONIZING RADIATION; PREDICTOR VARIABLE; PRIORITY JOURNAL; RADIOSENSITIVITY; RADIOSENSITIZATION; SQUAMOUS CELL CARCINOMA; TUMOR CELL;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CELL TRANSFORMATION, NEOPLASTIC; CURCUMIN; ENZYME ACTIVATION; GENE KNOCKDOWN TECHNIQUES; HELA CELLS; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; RADIATION-SENSITIZING AGENTS; REACTIVE OXYGEN SPECIES; THIOREDOXIN REDUCTASE 1;

EID: 77950287159     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-09-3025     Document Type: Article

References (41)

1. Howells LM, Moiseeva EP, Neal CP, et al. Predicting the physiological relevance of in vitro cancer preventive activities of phytochemicals. Acta Pharmacol Sin 2007;28:1274-1304
2. Goel A, Kunnumakkara AB, Aggarwal BB. Curcumin as "curecumin": from kitchen to clinic. Biochem Pharmacol 2008;75:787-809.
3. Javvadi P, Segan AT, Tuttle SW, Koumenis C. The chemopreventive agent curcumin is a potent radiosensitizer of human cervical tumor cells via increased reactive oxygen species production and over-activation of the mitogen-activated protein kinase pathway. Mol Pharmacol 2008;73:1491-1501
4. Chendil D, Ranga RS, Meigooni D, Sathishkumar S, Ahmed MM. Curcumin confers radiosensitizing effect in prostate cancer cell line PC-3. Oncogene 2004;23:1599-1607
5. Khafif A, Hurst R, Kyker K, Fliss DM, Gil Z, Medina JE. Curcumin: a new radio-sensitizer of squamous cell carcinoma cells. Otolaryngol Head Neck Surg 2005;132:317-321
6. Okunieff P, Xu J, Hu D, et al. Curcumin protects against radiation-induced acute and chronic cutaneous toxicity in mice and decreases mRNA expression of inflammatory and fibrogenic cytokines. Int J Radiat Oncol Biol Phys 2006;65:890-898
7. Choudhary D, Chandra D, Kale RK. Modulation of radioresponse of glyoxalase system by curcumin. J Ethnopharmacol 1999;64:1-7.
8. Fang J, Lu J, Holmgren A. Thioredoxin reductase is irreversibly modified by curcumin: a novel molecular mechanism for its anticancer activity. J Biol Chem 2005;280:25284-25290
9. Mustacich DP, Powis G. G. Thioredoxin reductase. Biochem J 2000;346:1-8.
10. Becker K, Gromer S, Schirmer RH, Müller S. Thioredoxin reductase as a pathophysiological factor and drug target. Eur J Biochem 2000;267:6118-6125
11. Karimpour S, Lou J, Lin LL, et al. Thioredoxin reductase regulates AP-1 activity as well as thioredoxin nuclear localization via active cysteines in response to ionizing radiation. Oncogene 2002;21:6317-6327
12. Smart DK, Ortiz KL, Mattson D, et al. Thioredoxin reductase as a potential molecular target for anticancer agents that induce oxidative stress. Cancer Res 2004;64:6716-6724
13. Choi JH, Kim TN, Kim S, et al. Overexpression of mitochondrial thioredoxin reductase and peroxiredoxin III in hepatocellular carcinomas. Anticancer Res 2002;22:3331-3335
14. Lincoln DT, Ali Emadi EM, Tonissen KF, Clarke FM. The thioredoxinthioredoxin reductase system: over-expression in human cancer. Anticancer Res 2003;23:2425-2433
15. Carde P, Timmerman R, Mehta MP, et al. Multicenter phase Ib/II trial of the radiation enhancer motexafin gadolinium in patients with brain metastases. J Clin Oncol 2001;19:2074-2083
16. Urig SBK. On the potential of thioredoxin reductase inhibitors for cancer therapy. Semin Cancer Biol 2006;16:452-465
17. Koumenis C, Naczk IC, Koritzinsky M, et al. Regulation of protein synthesis by hypoxia via activation of the endoplasmic reticulum kinase PERK and phosphorylation of the translation initiation factor eIF2a. Mol Cell Biol 2002;22:7405-7416
18. Tamura T, Stadtman TC. A new selenoprotein from human lung adenocarcinoma cells: purification, properties, and thioredoxin reductase activity. Proc Natl Acad Sci U S A 1996;93:1006-1011
19. Arnér ESJ, Nordberg J, Holmgren A. Efficient reduction of lipoamide and lipoic acid by mammalian thioredoxin reductase. Biochem Biophys Res Commun 1996;225:268-274
20. Biaglow JE, Donahue J, Tuttle S, Held K, Chrestensen C, Mieyal J. A method for measuring disulfide reduction by cultured mammalian cells: relative contributions of glutathione-dependent and glutathione-independent mechanisms. Anal Biochem 2000;281:77-86.
21. Syng-ai C, Kumari AL, Khar A. Effect of curcumin on normal and tumor cells: role of glutathione and bcl-2. Mol Cancer Ther 2004;3:1101-1108
22. Somparn P, Phisalaphong C, Nakornchai S, Unchern S, Morales NP. Comparative antioxidant activities of curcumin and its demethoxy and hydrogenated derivatives. Biol Pharm Bull 2007;30:74-78
23. Brandt R, Keston AS. Synthesis of dichlorodihydrofluorescin: a stable reagent for fluorometric analysis. Anal Biochem 1965;11:6-9.
24. Nalvarte I, Damdimopoulos AE, Nystom C, et al. Overexpression of enzymatically active human cytosolic and mitochondrial thioredoxin reductase in HEK-293 cells: effect on cell growth and differentiation. J Biol Chem 2004;279:54510-54517
25. Gasdaska JR, Harney JW, Gasdaska PY, Powis G, Berry MJ. Regulation of human thioredoxin reductase expression and activity by 3′-untranslated region selenocysteine insertion sequence and mRNA instability elements. J Biol Chem 1999;274:25379-25385
26. Inano H, Onoda M. Radioprotective action of curcumin extracted from curcuma longa LINN: inhibitory effect on formation of urinary 8-hydroxy-2-deoxyguanosine, tumorigenesis, but not mortality, induced by γ-ray irradiation. Int J Radiat Oncol Biol Phys 2002;53:735-743
27. Thresiamma KC, George J, Kuttan R. Protective effect of curcumin, ellagic acid and bixin on radiation induced toxicity. Indian J Exp Biol 1996;34:845-847
28. Kunnumakkara AB, Diagaradjane P, Guha S, et al. Curcumin sensitizes human colorectal cancer xenografts in nude mice to {γ}-radiation by targeting nuclear factor-{κ}B-regulated gene products. Clin Cancer Res 2008;14:2128-2136
29. Li M, Zhang Z, Hill DL, Wang H, Zhang R. Curcumin, a dietary component, has anticancer, chemosensitization, and radiosensitization effects by down-regulating the MDM2 oncogene through the PI3K/mTOR/ETS2 pathway. Cancer Res 2007;67:1988-1996
30. Kunnumakkara AB, Diagaradjane P, Guha S, et al. Curcumin sensitizes human colorectal cancer xenografts in nude mice to {γ}-radiation by targeting nuclear factor-{κ} B-regulated gene products. Clin Cancer Res 2008;14:2128-2136.
31. Dhandapani KM, Mahesh VB, Brann DW. Curcumin suppresses growth and chemoresistance of human glioblastoma cells via AP-1 and NFeκB transcription factors. J Neurochem 2007;102:522-538
32. Toyokuni S, Okamoto K, Yodoi J, Hiai H. Persistent oxidative stress in cancer. FEBS Lett 1995;358:1-3.
33. Pervaiz S, Clement MV. Tumor intracellular redox status and drug resistance - serendipity or a causal relationship? Curr Pharm Des 2004;10:1969-1977
34. Tiligada E. Chemotherapy: induction of stress responses. Endocr Relat Cancer 2006;13:S115-24.
35. Yoo M, Xu X, Carlson BA, Gladyshev VN, Hatfield DL. Thioredoxin reductase 1 deficiency reverses tumor phenotype and tumorigenicity of lung carcinoma cells. J Biol Chem 2006;281:13005-13008
36. Kirkpatrick DL, Kuperus M, Dowdeswell M, et al. Mechanisms of inhibition of the thioredoxin growth factor system by antitumor 2-imidazolyl disulfides. Biochem Pharmacol 1998;55:987-994
37. Magda D, Lepp C, Gerasimchuk N, et al. Redox cycling by motexafin gadolinium enhances cellular response to ionizing radiation by forming reactive oxygen species. Int J Radiat Oncol Biol Phys 2001;51:1025-1036
38. Rockwell S, Donnelly ET, Liu Y, Tang L. Preliminary studies of the effects of gadolinium texaphyrin on the growth and radiosensitivity of EMT6 cells in vitro. Int J Radiat Oncol Biol Phys 2002;54:536-541
39. Gius D. Redox-sensitive signaling factors and antioxidants: how tumor cells respond to ionizing radiation. J Nutr 2004;134:3213S-4S.
40. Von Roretz C, Gallouzi I. Decoding ARE-mediated decay: is micro-RNA part of the equation? J Cell Biol 2008;181:189-194
41. Moos PJ, Edes K, Mullally JE, Fitzpatrick FA. Curcumin impairs tumor suppressor p53 function in colon cancer cells. Carcinogenesis 2004;25:1611-1617